Minaris Advanced Testing, with over 40 years of expertise in biosafety and analytical testing, is a trusted partner for vaccine characterization and lot release.
Vaccines
Advanced Testing Support for Viral and Protein-Based Vaccines
Advanced Testing Support for Viral and Protein-Based Vaccines
Global Reach, Regulatory Confidence
The FDA- and EMA-certified, state-of-the-art facility in Philadelphia, Pennsylvania, offers both regional access and global capacity. Our unified quality systems, proven regulatory track record and integrated QC testing ensure confidence at every phase, from early development through commercial launches.
Knowledge Center
Explore More Resources
Through our Knowledge Center, we share data-driven insights and best practices from across the industry to help you stay ahead of evolving expectations.
intro-section does not exist
Contact Us
Minaris Advanced Therapies is dedicated to helping innovators in cell and gene therapy succeed. Whether you are in early-stage development or preparing for commercial launch, our end-to-end expertise, global reach and commitment to quality make us the ideal partner for cell and gene therapy manufacturing and GMP biosafety and analytical testing of all biologics.